• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

胰腺癌术前和术后癌胚抗原(CEA)及糖类抗原19.9(CA19.9)水平的预后价值

Prognostic values of preoperative and postoperative CEA and CA19.9 levels in pancreatic cancer.

作者信息

Yasue M, Sakamoto J, Teramukai S, Morimoto T, Yasui K, Kuno N, Kurimoto K, Ohashi Y

机构信息

Department of Surgery, Aichi Prefectural Hospital, Okazaki, Japan.

出版信息

Pancreas. 1994 Nov;9(6):735-40. doi: 10.1097/00006676-199411000-00011.

DOI:10.1097/00006676-199411000-00011
PMID:7846017
Abstract

Preoperative serum levels of carcinoembryonic antigen (CEA) and/or carbohydrate antigen 19.9 (CA19.9) were measured in 90 patients with advanced pancreatic cancer. CEA antigen was above the cutoff levels of 5.0 ng/ml in 51% of patients and CA19.9 was above the cutoff limit of 37 U/ml in 87% of patients. High preoperative CEA and CA19.9 levels were related to a poor prognosis of the patients. In multivariate analysis, the hazard rate was significantly higher in the high-CEA group (> 2.5 ng/ml) compared to the low-CEA group (< 2.4 ng/ml). An increase in CEA and/or CA19.9 within 1 month after the operation was also significantly related to the hazard rate. This study reconfirms the prognostic importance of preoperative and postoperative CEA and CA19.9.

摘要

对90例晚期胰腺癌患者术前测定癌胚抗原(CEA)和/或糖类抗原19.9(CA19.9)的血清水平。51%的患者CEA抗原高于5.0 ng/ml的临界值,87%的患者CA19.9高于37 U/ml的临界值。术前CEA和CA19.9水平高与患者预后不良相关。在多变量分析中,高CEA组(>2.5 ng/ml)的风险率显著高于低CEA组(<2.4 ng/ml)。术后1个月内CEA和/或CA19.9升高也与风险率显著相关。本研究再次证实术前和术后CEA及CA19.9对预后的重要性。

相似文献

1
Prognostic values of preoperative and postoperative CEA and CA19.9 levels in pancreatic cancer.胰腺癌术前和术后癌胚抗原(CEA)及糖类抗原19.9(CA19.9)水平的预后价值
Pancreas. 1994 Nov;9(6):735-40. doi: 10.1097/00006676-199411000-00011.
2
Preoperative CEA and CA 19-9 are prognostic markers for survival after curative resection for ductal adenocarcinoma of the pancreas - a retrospective tumor marker prognostic study.术前 CEA 和 CA 19-9 是可切除性胰腺导管腺癌患者生存的预后标志物——一项回顾性肿瘤标志物预后研究。
Int J Surg. 2013;11(10):1067-72. doi: 10.1016/j.ijsu.2013.10.005. Epub 2013 Oct 23.
3
The clinical value of serum CEA, CA19-9, and CA242 in the diagnosis and prognosis of pancreatic cancer.血清癌胚抗原(CEA)、糖类抗原19-9(CA19-9)和糖类抗原242(CA242)在胰腺癌诊断及预后中的临床价值
Eur J Surg Oncol. 2005 Mar;31(2):164-9. doi: 10.1016/j.ejso.2004.09.007.
4
Postoperative carcinoembryonic antigen as a complementary tumor marker of carbohydrate antigen 19-9 in pancreatic ductal adenocarcinoma.术后癌胚抗原作为胰腺导管腺癌中糖类抗原19-9的补充肿瘤标志物。
J Korean Med Sci. 2015 Mar;30(3):259-63. doi: 10.3346/jkms.2015.30.3.259. Epub 2015 Feb 16.
5
Clinical importance of preoperative carcinoembryonic antigen and carbohydrate antigen 19-9 levels in gastric cancer.术前癌胚抗原和糖类抗原19-9水平在胃癌中的临床意义
J Clin Gastroenterol. 2001 Jan;32(1):41-4. doi: 10.1097/00004836-200101000-00010.
6
Applicative Value of Serum CA19-9, CEA, CA125 and CA242 in Diagnosis and Prognosis for Patients with Pancreatic Cancer Treated by Concurrent Chemoradiotherapy.血清CA19-9、CEA、CA125和CA242在同步放化疗治疗的胰腺癌患者诊断及预后中的应用价值
Asian Pac J Cancer Prev. 2015;16(15):6569-73. doi: 10.7314/apjcp.2015.16.15.6569.
7
Combination of the serum carbohydrate antigen 19-9 and carcinoembryonic antigen is a simple and accurate predictor of mortality in pancreatic cancer patients.血清糖类抗原19-9与癌胚抗原联合检测是胰腺癌患者死亡率的一种简单而准确的预测指标。
Surg Today. 2014 Sep;44(9):1692-701. doi: 10.1007/s00595-013-0752-9. Epub 2013 Oct 9.
8
Can preoperative CA19-9 and CEA levels predict the resectability of patients with pancreatic adenocarcinoma?术前 CA19-9 和 CEA 水平能否预测胰腺腺癌患者的可切除性?
J Gastroenterol Hepatol. 2009 Dec;24(12):1869-75. doi: 10.1111/j.1440-1746.2009.05935.x.
9
The usefulness of CEA and/or CA19-9 in monitoring for recurrence in gastric cancer patients: a prospective clinical study.癌胚抗原(CEA)和/或糖类抗原19-9(CA19-9)在监测胃癌患者复发中的应用:一项前瞻性临床研究。
Gastric Cancer. 2003;6(3):142-5. doi: 10.1007/s10120-003-0240-9.
10
[Prognostic value of carcinoembryonic antigen, alpha fetoprotein, carbohydrate antigen 125 and carbohydrate antigen 19-9 in gastroenteropancreatic neuroendocrine neoplasms].癌胚抗原、甲胎蛋白、糖类抗原125和糖类抗原19-9在胃肠胰神经内分泌肿瘤中的预后价值
Zhonghua Wei Chang Wai Ke Za Zhi. 2017 Sep 25;20(9):1002-1008.

引用本文的文献

1
Performance of different CT enhancement quantification methods as predictors of pancreatic cancer recurrence after upfront surgery.不同 CT 增强量化方法在预测术前手术治疗后胰腺癌复发中的表现。
Sci Rep. 2024 Aug 26;14(1):19783. doi: 10.1038/s41598-024-70441-3.
2
Predicting Adverse Pathologic Features and Clinical Outcomes of Resectable Pancreas Cancer With Preoperative CA 19-9.术前CA 19-9预测可切除胰腺癌的不良病理特征及临床结局
Front Oncol. 2021 May 11;11:651119. doi: 10.3389/fonc.2021.651119. eCollection 2021.
3
Diagnostic model for pancreatic cancer using a multi-biomarker panel.
使用多生物标志物组合的胰腺癌诊断模型
Ann Surg Treat Res. 2021 Mar;100(3):144-153. doi: 10.4174/astr.2021.100.3.144. Epub 2021 Feb 26.
4
Prognostic Nutritional Index After Chemoradiotherapy Was the Strongest Prognostic Predictor Among Biological and Conditional Factors in Localized Pancreatic Ductal Adenocarcinoma Patients.在局部胰腺导管腺癌患者的生物学和条件因素中,放化疗后的预后营养指数是最强的预后预测指标。
Cancers (Basel). 2019 Apr 10;11(4):514. doi: 10.3390/cancers11040514.
5
Evidence of Altered Glycosylation of Serum Proteins Prior to Pancreatic Cancer Diagnosis.在胰腺癌诊断之前存在血清蛋白糖基化改变的证据。
Int J Mol Sci. 2017 Dec 9;18(12):2670. doi: 10.3390/ijms18122670.
6
Prognostic Scoring Index for Patients with Metastatic Pancreatic Adenocarcinoma.转移性胰腺腺癌患者的预后评分指数。
Cancer Res Treat. 2016 Oct;48(4):1253-1263. doi: 10.4143/crt.2015.400. Epub 2016 Feb 3.
7
Indications for staging laparoscopy in pancreatic cancer.胰腺癌分期腹腔镜检查的适应证
HPB (Oxford). 2016 Jan;18(1):13-20. doi: 10.1016/j.hpb.2015.10.004. Epub 2015 Nov 18.
8
Postoperative carcinoembryonic antigen as a complementary tumor marker of carbohydrate antigen 19-9 in pancreatic ductal adenocarcinoma.术后癌胚抗原作为胰腺导管腺癌中糖类抗原19-9的补充肿瘤标志物。
J Korean Med Sci. 2015 Mar;30(3):259-63. doi: 10.3346/jkms.2015.30.3.259. Epub 2015 Feb 16.
9
At which stage of gastric cancer progression do levels of carcinoembryonic antigen and carbohydrate antigen 19-9 increase? Application in advanced gastric cancer treatment.癌胚抗原和糖类抗原 19-9 水平在胃癌进展的哪个阶段升高?在晚期胃癌治疗中的应用。
J Gastric Cancer. 2014 Jun;14(2):123-8. doi: 10.5230/jgc.2014.14.2.123. Epub 2014 Jun 30.
10
Biomarkers as predictors of recurrence following curative resection for pancreatic ductal adenocarcinoma: a review.生物标志物作为胰腺导管腺癌根治性切除术后复发的预测指标:综述
Biomed Res Int. 2014;2014:468959. doi: 10.1155/2014/468959. Epub 2014 Jun 24.